<DOC>
	<DOCNO>NCT01934231</DOCNO>
	<brief_summary>Acute Bacterial Rhinosinusitis ( ABRS ) respiratory inflammation commonly see clinical practice , respiratory symptom include nasal congestion , rhinorrhoea , postnasal discharge cough associate headache , cheek pain , facial pressure condition . The principal bacterial pathogen cause ABRS include Streptococcus pneumoniae , Haemophilus influenzae Moraxella ( Branhamella ) catarrhalis . These three bacteria account approximately 90 % ABRS child less equal 5 year age . Combination Potassium Clavulanate ( CVA ) Amoxicillin ( AMPC ) produce high antibiotic activity beta-lactamase-producing bacteria . The present study design assess clinical efficacy , bacteriological efficacy safety CVA/AMPC ( 1:14 ) administer child age 3 month le 15 year ABRS . It open-label study consist 7-day treatment phase post-treatment follow-up phase 7 14 day .</brief_summary>
	<brief_title>Study Assess Efficacy Safety Potassium Clavulanate/Amoxicillin Children With Acute Bacterial Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Child ABRS inflammation bacterial infection follow symptoms/signs day day first dose investigational product : Redness nasal mucosa ; nasal postnasal discharge purulent mucopurulent ; Pathological shadow paranasal sinus radiogram ( reference ) . Patient surgical history exclude patient pervious surgery 365 day apparently preserve maxillary sinus mucosa patient previous surgery nasal polypectomy 90 day may enrol study . Child ABRS whose severity classify moderate severe ( total score &gt; =4 ) base nasal cavity finding symptom . Boy girl age &gt; =3 month &lt; 15 year . Body weight &gt; =6 kilogram ( kg ) &lt; 40 kg . Written inform consent obtain child 's legally acceptable representative . If child 12 year old , child him/herself also provide write informed consent . The investigator ( subinvestigator ) attempt obtain write informed consent child him/herself far possible even child less 12 year age . Severe infection require surgical treatment ( e.g. , child systemic symptom fever associate swell face , child almost full nasal obstruction due large nasal polyp ) . Serious complication acute mastoiditis , facial palsy , bacterial meningitis , brain tumor . Congenital disorder maxillofacial dysplasia . Need concomitant use antibiotic . Serious underlying disease ( e.g. , cardiac disease , malignancy , juvenile diabetes ) . Concurrent infection associate gastrointestinal symptom ( e.g. , diarrhoea , vomit ) may affect safety assessment . Known hypersensitivity component CVA/AMPC penicillin cephem antibiotic , past history serious adverse reaction possibly related agent . Infectious mononucleosis . Current hepatic impairment , past history jaundice hepatic impairment due component CVA/AMPC . Past current renal impairment ( e.g. , serum creatinine &gt; =1.5 Ã— Upper Limit Normal , creatinine clearance le 30 milliliter/liter [ mL/L ] ) . Past current immune dysfunction insufficiency , use immunosuppressive therapy . Need corticosteroid systemic , eye drop nasal drop . Phenylketonuria . Use azithromycin within 14 day prior first dose investigational product . Use antibiotic within 7 day prior first dose investigational product . Current use imperative use study period probenecid tubular secretion inhibitor . Participation another clinical study within 3 month prior enrollment , prospect participation another clinical study period study . Girl menstruation childbearing potential , pregnant girl , lactate girl , girl planning pregnancy study period . A girl childbearing potential may enrol study willing use least one follow acceptable measure contraception throughout study period : Male partner sterilization prior girl 's entry study , male sole partner girl ; Intrauterine device ( IUD ) ( document annual failure rate estimate &lt; 1 % ) ; Abstinence ; Male condom combine female diaphragm , either without vaginal spermicide . The legally acceptable representative minor . Child care . History alcohol drug abuse . Relationship study medical institution : The investigator , subinvestigator , study collaborator , person employ investigator study medical institution , close relative . Child whose participation study consider inappropriate investigator ( subinvestigator ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acute bacterial rhinosinusitis</keyword>
	<keyword>Amoxicilin</keyword>
	<keyword>Infection</keyword>
	<keyword>Potassium clavulanate</keyword>
</DOC>